Gwynne et al. utilized the CRISPR-Cas9 loss-of-function screen for a patient-derived MYC-activated group 3 MB cell line and uncovered that DHODH sustained the transcriptional activity of c-Myc and drove cell-cycle progression in MYC-amplified group 3 MBs [71]. Here, MYC is linked to Mobius syndrome.